Information on ongoing clinical drug trials worldwide can be accessed through the several channels.

Several approaches can be employed to swiftly follow the latest global developments in new drug research and development.

The process of bringing a new drug from research and development to market is a long and complex journey.

The high failure rate of clinical trials, often cited to be around 90%, can be attributed to several factors.

Individuals who should not take semaglutide are:Those with multiple endocrine neoplasia type 2 (MEN2),medullary thyroid cancer,diabetic ketoacidosis (DKA)

Semaglutide, a glucagon-like peptide-1 (GLP-1) agonist, is a medication used for weight loss, type 2 diabetes management, and cardiovascular risk reduction.

The sponsor of a clinical trial, which may be a pharmaceutical company or an academic institution, is responsible for submitting information about their study to the ClinicalTrials.gov database.

ClinicalTrials.gov is a public database that contains information on clinical trials conducted around the world.

The drug packaging box sent to the subject will be returned to the investigator by the subject after the end of the trial.

Concomitant medication refers to the drugs that the subjects take at the same time as the trial drugs in clinical trials.

Laboratory tests are often part of the safety assessment in clinical trials of unlisted drugs, and blood samples are used for clinical biochemistry and blood.

The trial protocol should strictly define what subjects can be enrolled (enrollment criteria) and what subjects cannot be enrolled (exclusion criteria).